Par Drugs And Chemicals Ltd (PAR) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

BSE: 0 | NSE: PAR | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Par Drugs & Chem.

Based on:

M-Cap below 100cr DeciZen not available

Par Drugs And Chemicals stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
6.95
Market Cap:
96.7 Cr.
52-wk low:
0
52-wk high:
0

Is Par Drugs And Chemicals Ltd an attractive stock to invest in?

1. Is Par Drugs And Chemicals Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Par Drugs And Chemicals Ltd is a good quality company.

2. Is Par Drugs And Chemicals Ltd undervalued or overvalued?

The key valuation ratios of Par Drugs And Chemicals Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

3. Is Par Drugs And Chemicals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Par Drugs And Chemicals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Par Drugs & Chem.:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Par Drugs And Chemicals Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 9.4%12.3%11.2%12.4%15.6%28.7%21.9%23.2%25%19.5%-
Value Creation
Index
-0.3-0.1-0.2-0.10.11.10.60.70.80.4-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 33.348.842.446.355.960.875.195.895.6101106
Sales YoY Gr.-46.6%-13.1%9.3%20.6%8.8%23.6%27.6%-0.1%5.6%-
Adj EPS 0.83.42.82.83.98.37.59.111.810.311.3
YoY Gr.-337.2%-17.3%-0.4%37%115.8%-9.9%21.8%29.2%-13%-
BVPS (₹) 21.524.928.232.43342.448.757.969.680.490.4
Adj Net
Profit
0.41.81.52.54.710.29.211.214.512.614
Cash Flow from Ops. 6.59.24.73.47.712.17.613.420.316.2-
Debt/CF from Ops. 4.72.753.50.80.70000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 13.1%12.6%10.4%5.6%
Adj EPS 33.1%21.6%11%-13%
BVPS15.8%19.5%18.2%15.6%
Share Price - -8.7% -17.5% -7.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2.510.17.610.113.62216.417.118.513.713.2
Op. Profit
Mgn %
21.617.418.917.716.926.421.71923.919.317
Net Profit
Mgn %
1.33.83.65.48.516.812.311.715.212.513.1
Debt to
Equity
1.81.31.10.40.20.20000-
Working Cap
Days
15310811010293101105948883104
Cash Conv.
Cycle
5133294238303234353074

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 10.38%

Net Profit is growing at healthy rate in last 3 years 11.02%

Return on Equity has declined versus last 3 years average to 13.20%

Sales growth is not so good in last 4 quarters at 8.25%

Latest Financials - Par Drugs And Chemicals Ltd.

Standalone Consolidated
TTM EPS (₹) 11.3 -
TTM Sales (₹ Cr.) 106 -
BVPS (₹.) 90.4 -
Reserves (₹ Cr.) 99 -
P/BV 0.87 -
PE 6.95 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 96.7
Equity (₹ Cr.) 12.3
Face Value (₹) 10
Industry PE 40.8

Management X-Ray of Par Drugs & Chem.:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Par Drugs & Chem. - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Par Drugs & Chem.

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales33.2648.7742.3846.3255.8560.7575.0795.7595.64100.97
Operating Expenses 26.0840.3134.3538.1246.4144.7458.8277.5472.8281.47
Manufacturing Costs8.2511.909.7311.5714.0413.5317.7822.6522.1025.65
Material Costs12.8621.0717.9319.2223.6621.8828.8240.3333.7938.13
Employee Cost 1.791.842.012.212.822.692.723.343.834.17
Other Costs 3.185.504.695.115.886.649.4911.2313.1013.52
Operating Profit 7.198.468.038.209.4416.0116.2518.2122.8219.50
Operating Profit Margin (%) 21.6%17.4%18.9%17.7%16.9%26.4%21.7%19.0%23.9%19.3%
Other Income 0.040.040.040.090.100.190.180.240.242.15
Interest 3.572.502.331.960.790.640.450.130.110.08
Depreciation 2.652.823.143.042.762.823.283.233.443.65
Exceptional Items 000001.990000
Profit Before Tax 1.013.182.603.295.9914.7312.7015.0819.5217.92
Tax 0.591.341.070.781.233.113.493.755.024.57
Profit After Tax 0.421.851.522.514.7611.619.2111.3314.5013.36
PAT Margin (%) 1.3%3.8%3.6%5.4%8.5%19.1%12.3%11.8%15.2%13.2%
Adjusted EPS (₹)0.83.42.82.83.99.47.59.211.810.9
Dividend Payout Ratio (%)0%0%0%0%32%0%17%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 17.3619.2020.9629.0340.6152.2159.8871.2485.6398.97
Share Capital 8.458.458.454.486.156.1512.3012.3012.3012.30
Reserves 8.9110.7512.5124.5534.4646.0647.5758.9373.3386.67
Minority Interest0000000000
Debt26.4820.8317.6810.354.627.640000
Long Term Debt16.4914.3012.596.034.624.390000
Short Term Debt106.535.084.3203.250000
Trade Payables6.447.785.264.936.206.7210.668.095.3610.89
Others Liabilities 7.768.239.986.968.689.818.159.5410.629.52
Total Liabilities 58.0356.0453.8851.2760.1276.3878.6988.87101.61119.39

Fixed Assets

Gross Block54.1355.7356.3656.7157.3252.5460.0267.5773.8475.09
Accumulated Depreciation11.5314.1917.3320.3722.9222.6325.9129.1232.5336.18
Net Fixed Assets 42.6141.5339.0436.3434.4029.9134.1038.4541.3138.91
CWIP 00000.744.520.250.250.030
Investments 0.060.060.060.060.060.010.010.010.0125.07
Inventories5.583.994.074.292.9234.715.384.186.11
Trade Receivables7.388.118.728.5212.3712.4518.4716.9713.7116.71
Cash Equivalents 0.930.020.060.037.3821.1616.2122.2436.6527.58
Others Assets 1.482.331.942.032.265.334.945.575.725.01
Total Assets 58.0356.0453.8851.2760.1276.3878.6988.87101.61119.39

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 6.539.174.653.367.6912.097.6213.3820.2516.16
PBT 1.013.182.603.295.9914.7312.7015.0819.5217.92
Adjustment 6.115.225.034.313.411.293.463.023.092.58
Changes in Working Capital -0.551.45-2.6-3.54-0.85-0.34-5.43-0.4620.17
Tax Paid -0.04-0.68-0.38-0.71-0.85-3.59-3.12-4.26-4.36-4.52
Cash Flow From Investing Activity -0.17-1.70-0.60-0.25-1.460.05-3.02-7.34-5.84-25.24
Capex -0.15-1.73-0.64-0.34-1.53-0.13-3.20-7.43-6.07-1.23
Net Investments -0.0600000.0500-0-25.06
Others 0.040.030.040.090.080.130.180.100.231.05
Cash Flow From Financing Activity -5.46-8.38-4-3.141.111.65-9.55-000
Net Proceeds from Shares 00068.5300000
Net Proceeds from Borrowing -5.09-2.47-1.49-6.56-1.41-0.23-4.39000
Interest Paid -3.50-2.44-1.99-1.81-0.75-0.60-0.38-000
Dividend Paid -0-0-0-0-0.77-0.77-1.54000
Others 3.13-3.47-0.52-0.76-4.483.25-3.25000
Net Cash Flow 0.90-0.910.05-0.037.3513.78-4.966.0414.41-9.08

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)3.6914.7510.6311.3513.6825.0216.4417.2918.4914.47
ROCE (%)9.3612.3411.1912.4115.5628.6821.8523.225.0219.51
Asset Turnover Ratio0.570.860.881.011.141.011.091.291.131.03
PAT to CFO Conversion(x)15.554.963.061.341.621.040.831.181.41.21
Working Capital Days
Receivable Days82586359606667605249
Inventory Days52363029211617171617
Payable Days1841231339786108110857378

Par Drugs And Chemicals Ltd Stock News

Par Drugs And Chemicals Ltd FAQs

The current trading price of Par Drugs & Chem. on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Par Drugs & Chem. stood at ₹96.69.
The latest P/E ratio of Par Drugs & Chem. as of 31-Dec-1969 is 6.95.
The latest P/B ratio of Par Drugs & Chem. as of 31-Dec-1969 is 0.87.
The 52-week high of Par Drugs & Chem. is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Par Drugs & Chem. is ₹106 ( Cr.) .

About Par Drugs And Chemicals Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×